CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S - share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk announced continuation of its share repurchase programme initiated on 6 May 2026, part of a DKK 15 billion buyback program to be executed over 12 months beginning 4 February 2026.

Importance:2/10
Sentiment:
0.00
share repurchasecapital allocationshareholder return
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 27, 2026 10:48 AM

Read Original